Company also acquires St. Louis-based Radiologics
Health Care + Med Tech
The raise will provide “three years of cash” for the company to secure FDA approval for its prostate cancer treatment.
Working in concert with five health industry companies, the university is establishing a new center devoted to cybersecurity for medical devices.
The Brooklyn Park-based company’s implant technology to treat heart failure is in clinical trials.
Though the company's revenue is booming, its losses are also growing.
The health insurance company held its IPO last month.
A former female employee sues the med tech giant for sexual harassment, discrimination.
Medical device company offering more shares at higher price
Geoff Martha is building a global company designed to develop products faster through a new decentralized operating model.
The Minnesota-based health insurance provider is offering fewer shares at lower price than previously outlined
With financial help from the state of Minnesota, Silk Road Medical is opening an office in Plymouth.
Venture funds now own 59 percent of company.
The biggest little drug store you never heard of became ubiquitous this spring.
Goodness Growth, formerly known as Vireo Health, has unveiled plans to explore psychedelics for the treatment of depression and other psychiatric disorders.
The medical device maker sells an implantable product aimed at treating heart failure.
The company’s heart failure device, known as HVAD, was associated with a higher frequency of “neurological adverse events” compared to other products on the market.
The company has had scattered initiatives in the past, but the latest program codifies all of its efforts under one umbrella.
The company, which hasn’t yet turned a profit, forecasts a multibillion-dollar market for its lab-made livers and kidneys.
The small-format clinics are set to open in St. Louis Park, Eden Prairie, and St. Paul.
In the last days of the 2021 legislative session, state lawmakers approved the sale of smokable cannabis for medical patients. Minnesota’s two medical marijuana manufacturers say the move will make the plant more affordable.